Showing results (291-300 of 345) with videos related to
Sort By:
Pageof 35
Atherosclerosis|November 1, 1993
Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemiaM D Feher, J C Webb, D D Patel, et al.Journal of Surgical Oncology|June 1, 1997
Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma: an immunohistochemical approachD D Patel, J M Bhatavdekar, P R Chikhlikar, et al.Neoplasma|January 1, 1992
Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survivalJ M Bhatavdekar, D D Patel, N H Karelia, et al.Breast Cancer Research and Treatment|January 1, 1994
Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary studyJ M Bhatavdekar, D D Patel, N H Karelia, et al.Journal of Lipid Research|August 1, 1994
Partial duplication of the EGF precursor homology domain of the LDL-receptor protein causing familial hypercholesterolemia (FH-Salerno)S Bertolini, D D Patel, D A Coviello, et al.Annals of Surgical Oncology|May 20, 2000
Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysisJ M Bhatavdekar, D D Patel, N G Shah, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 18, 2000
Prolactin as a local growth promoter in patients with breast cancer: GCRI experienceJ M Bhatavdekar, D D Patel, N G Shah, et al.Arthritis Research|February 15, 2001
The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)M C Kraan, D D Patel, J J Haringman, et al.The International Journal of Biological Markers|July 1, 1989
Comparison of prolactin, CA 15-3 and TPA in breast carcinomasJ M Bhatavdekar, S N Trivedi, N G Shah, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejectionL A Robinson, C Nataraj, D W Thomas, et al.Pageof 35